Finding a cure for cancer has been the mission of millions of scientists around the world. Significant breakthroughs have been made in developing treatments for cancer, and even some preventative measures have been developed like the HPV vaccine that guards against certain strains of the humanpapillomavirus, one of the few viral causes of cancer. But despite advances in immuno and virotherapy, there remains a need for an effective, easily produced, and easy to tolerate treatment for cancer.
Researchers working in part at the Mayo Clinic
in Rochester MN, and St. James University Hospital
in Leeds, UK believe they have developed a new virotherapy
with tremendous potential. Their method focuses on prostate cancer
in mice, and while very successful it remains to be seen whether this therapy could be translated with the same effectiveness into humans.